As part of our commitment to providing quality intensive care, the DCCM actively promotes research. The Treaty of Waitangi acts as a mandate for the good health of all New Zealanders and health research is an integral part of this. Research involves nurses, doctors, pharmacists, dieticians, and radiographers.

With modern intensive care most patients now survive, but some conditions continue to be very difficult to treat. To help improve the care of all patients, we are involved in research that helps us to determine which treatments are most effective and is an ongoing process to improve patient care.

Information for research participants

If you are asked by staff for consent for your family member to be involved in a research study, it is helpful to know that:

  • The care your family member receives will not be affected by their participation or non-participation in a research study.
  • Participation is voluntary. Consent may be withdrawn at any time without affecting the care your family member receives. Observational audits/studies which don't identify your family member may not always require consent.
  • Maori will be offered the same opportunities as non-Maori to participate in research and benefit from the results. Achieving a nation that manifests equity and fairness benefits the whole of Aotearoa and the right to collective wellbeing.
  • The DCCM is affiliated with the Australia and New Zealand Intensive Care Society Clinical Trials Group and the University of Auckland.
  • All research conducted has the prior approval of a New Zealand Health and Disability Ethics Committee or the Ministry of Health and the ADHB Research Office.

Useful research contacts

Research nurses

We welcome your comments and questions. You can phone the research nurses on 09 307 4949 ext 24800 and ask to speak to a research coordinator.

Māori research support

If you you have any specific concerns we encourage you to talk to your whānau first. Alternatively you are welcome to phone the administrator for He Kamaka Waiora (Māori health team) on 09 486 8324 ext 2324 or further information is available here.(external link) 

If you have any questions or complaints about any study, phone the Auckland and Waitematā District Health Boards Maori Research Committee or Maori Research Advisor on 09 486 8920 ext 3204.

Health and disability contacts

If you or your family member have any queries or concerns regarding your rights as a research participant, phone the Health and Disability Advocacy(external link) on 0800 555 050.

Current research studies

Our current research portfolio:

  • BEST-FLUIDS Page 1 Copy 3 Created with Sketch.

    Study looking into the best fluid for patients who have received a renal transplant.

  • PATCH Page 1 Copy 3 Created with Sketch.

    Pre-hospital treatment with tranexamic acid for severely injured patients at risk of acute traumatic coagulopathy.
    More information can be found here.

  • PLUS Page 1 Copy 3 Created with Sketch.

    Saline vs Plasma-Lyte for critically ill patients in ICU.
    More information can be found in the participant information leaflet and also the study protocol.

  • REMAP-CAP Page 1 Copy 3 Created with Sketch.

    Research study looking into the best way to treat infection in the lungs (pneumonia).
    More information can be found here.

  • STARRT-AKI Page 1 Copy 3 Created with Sketch.

    Looking at the timing to initiate renal replacement therapy for patients with severe acute kidney injury.
    More information can be found here.

  • TEAM Page 1 Copy 3 Created with Sketch.

    The TEAM study will test whether early activity and mobilisation is better in a large randomised controlled trial of 750 ICU patients. Eligible patients will be randomised to receive either early or standard  (usual care) activity and mobilisation.

  • TAME Page 1 Copy 3 Created with Sketch.

    A study comparing two different blood levels of carbon dioxide in patients who have had a cardiac arrest.  It may be that having a higher carbon dioxide level in the blood may be the best way to reduce brain damage after cardiac arrest, however we need to do a study to show if this is true.

  • BALANCE Page 1 Copy 3 Created with Sketch.

    This study is to determine whether, in critically ill patients with bloodstream infection, 7 days antibiotic treatment achieves the same outcomes compared to 14 days antibiotic treatment.

  • SCARLET-2 Page 1 Copy 3 Created with Sketch.

    Recombinant human soluble thrombomodulin (ART-123) in the treatment of Disseminated Intravascular Coagulation (DIC) complicating sepsis

  • LUCID Page 1 Copy 3 Created with Sketch.

    A Study comparing the conventional approach to control high blood glucose (‘sugar in the blood’) to a more liberal approach for patients with pre-existing diabetes.

  • PRISM-UDR Page 1 Copy 3 Created with Sketch.

    This study is to test a new antibiotic for patients on a breathing machine, who have developed pneumonia due possibly to a bacteria called Pseudomonas aeruginosa.

  • ICU-ROX Page 1 Copy 3 Created with Sketch.

    This is a study looking at two approaches to oxyen therapy in patients on a breathing machine.

Previous research results

Results of our previous reearch can be found below:

  • ART123 Page 1 Copy 3 Created with Sketch.
  • POLAR Page 1 Copy 3 Created with Sketch.
  • TARGET Page 1 Copy 3 Created with Sketch.